Jane Street Group, LLC Precigen, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 65,082 shares of PGEN stock, worth $48,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,082

Previous 124,085 47.55%

Holding current value

$48,811

Previous $196,000 68.88%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $53,692 - $110,925	-59,003 Reduced 47.55%	65,082 $61,000
Q2 2024 Aug 14, 2024	BUY	$1.27 - $1.75 $40,820 - $56,248	32,142 Added 34.96%	124,085 $196,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $138,247 - $199,944	-114,254 Reduced 55.41%	91,943 $133,000
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $154,172 - $244,251	173,228 Added 525.43%	206,197 $276,000
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $35,606 - $60,992	32,969 New	32,969 $46,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $16,120 - $40,118	18,319 New	18,319 $19,000
Q2 2022 Aug 16, 2022	BUY	$1.15 - $2.53 $196,890 - $433,158	171,209 Added 294.01%	229,441 $307,000
Q1 2022 May 17, 2022	SELL	$1.91 - $3.98 $6,379 - $13,293	-3,340 Reduced 5.42%	58,232 $123,000
Q4 2021 Feb 15, 2022	BUY	$3.53 - $5.5 $138,337 - $215,539	39,189 Added 175.08%	61,572 $229,000
Q3 2021 Nov 16, 2021	SELL	$4.99 - $6.55 $18,408 - $24,162	-3,689 Reduced 14.15%	22,383 $112,000
Q4 2020 Feb 17, 2021	SELL	$3.75 - $10.56 $201,026 - $566,089	-53,607 Reduced 67.28%	26,072 $266,000
Q3 2020 Nov 17, 2020	BUY	$3.5 - $6.2 $208,789 - $369,854	59,654 Added 297.9%	79,679 $279,000
Q2 2020 Aug 17, 2020	BUY	$2.16 - $5.46 $829 - $2,096	384 Added 1.96%	20,025 $100,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $28,675 - $141,218	19,641 New	19,641 $67,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Precigen, Inc. Transaction History